Worsening physical functioning in patients with neuroinflammatory disease during the COVID-19 pandemic

被引:9
|
作者
Levit, Elle [1 ]
Cohen, Inessa [1 ]
Dahl, Megan [4 ]
Edwards, Keith [8 ]
Weinstock-Guttman, Bianca [5 ]
Ishikawa, Toshinari [2 ]
Kavak, Katelyn [5 ]
Leavitt, Victoria [3 ]
Nelson, Katie [3 ]
Onomichi, Kaho [3 ]
Bar-Or, Amit [6 ,7 ]
Perrone, Christopher [6 ,7 ]
Riley, Claire [3 ]
Venkatesh, Shruthi [4 ]
De Jager, Philip L. [3 ]
Xia, Zongqi [4 ]
Longbrake, Erin E. [1 ]
机构
[1] Yale Univ, Dept Neurol, New Haven, CT 06510 USA
[2] Yale Univ, Sch Publ Hlth, New Haven, CT USA
[3] Columbia Multiple Sclerosis Ctr, Ctr Translat & Computat Neuroirumunol, Dept Neurol, New York, NY USA
[4] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA
[5] Univ Buffalo, Jacobs MS Ctr, Buffalo, NY USA
[6] Univ Penn, Ctr Neuroinflammat & Expt Therapeut, Philadelphia, PA 19104 USA
[7] Univ Penn, Div MS & Related Disorders, Philadelphia, PA 19104 USA
[8] MS Ctr Northeastern NY, Latham, NY USA
关键词
COVID19; Multiple sclerosis; Depression; QUALITY-OF-LIFE; MULTIPLE-SCLEROSIS; DEPRESSION; PEOPLE; VALIDATION; SYMPTOMS; ANXIETY;
D O I
10.1016/j.msard.2021.103482
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To quantify changes in psychological wellbeing and physical function as reported by people with neurological inflammatory disease (PwNID) during the COVID-19 pandemic.Methods: 1134 PwNID and 868 control participants were recruited through five major academic medical centers in the Northeast/Mid-Atlantic U.S. beginning in April 2020. Participants completed serial surveys throughout the COVID-19 pandemic that aimed to quantify mood symptoms and physical function, analyzed cross-sectionally with a smaller cohort analyzed longitudinally.Results: Throughout the pandemic, depression scores were not significantly different between PwNID and controls, although a higher proportion of PwNID reported clinically significant depression at study entry. Depression scores did not worsen over time for either group. Loneliness was the strongest predictor of worse depression, along with older age, male gender in both PwNID and controls, as well as lack of disease modifying therapy use, and disease duration in PwNID only. In contrast, physical disability worsened significantly over time for both PwNID and controls. Age, DMT status and comorbid health conditions emerged as significant predictors of physical function.Conclusions: Depressive symptoms remained consistent for both PwNID and controls throughout the COVID-19 pandemic, but physical function worsened significantly over time for both groups. This is particularly impactful for PwNID, who have higher baseline levels of physical disability, and underscores the importance of reinstituting services and interventions that facilitate exercise and reconditioning for this population.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Combating physical inactivity during the COVID-19 pandemic
    Pinto, Ana Jessica
    Dunstan, David W.
    Owen, Neville
    Bonfa, Eloisa
    Gualano, Bruno
    NATURE REVIEWS RHEUMATOLOGY, 2020, 16 (07) : 347 - 348
  • [22] Barriers To Physical Activity During The COVID-19 Pandemic
    Crowley, Shannon K.
    Gill, Madison
    Braxton, Danielle F.
    Magal, Meir
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2021, 53 (08): : 249 - 249
  • [23] Promoting Physical Activity during the COVID-19 Pandemic
    King, Kristi M.
    Hartson, Kimberly
    Della, Lindsay J.
    Terson de Paleville, Daniela
    ACSMS HEALTH & FITNESS JOURNAL, 2020, 24 (06) : 43 - 47
  • [24] A 6-month longitudinal study on worsening of Parkinson's disease during the COVID-19 pandemic
    Shalash, Ali
    Helmy, Asmaa
    Salama, Mohamed
    Gaber, Ahmed
    El-Belkimy, Mahmoud
    Hamid, Eman
    NPJ PARKINSONS DISEASE, 2022, 8 (01)
  • [25] A 6-month longitudinal study on worsening of Parkinson’s disease during the COVID-19 pandemic
    Ali Shalash
    Asmaa Helmy
    Mohamed Salama
    Ahmed Gaber
    Mahmoud El-Belkimy
    Eman Hamid
    npj Parkinson's Disease, 8
  • [26] Physical activity levels during COVID-19 pandemic and its associated factors in patients with Chagas disease
    Xavier, Isis Gabrielli Gomes
    Andrade, Patricia Mello
    Vitor, Rodrigo de Lima
    Barros, Tayna Cruz
    Portela, Luciana Fernandes
    de Holanda, Marcelo Teixeira
    Sangenis, Luiz Henrique Conde
    da Silva, Gilberto Marcelo Sperandio
    Mazzoli-Rocha, Flavia
    Mendes, Fernanda de Souza Nogueira Sardinha
    da Costa, Andrea Rodrigues
    Quintana, Marcel de Souza Borges
    Hasslocher-Moreno, Alejandro Marcel
    Araujo, Itaua Leston
    Junqueira, Angela Cristina Verissimo
    Pinheiro, Roberta Olmo
    Georg, Ingebourg
    Paravidino, Vitor Barreto
    Goncalves, Tatiana Rehder
    Saraiva, Roberto Magalhaes
    Mediano, Mauro Felippe Felix
    FRONTIERS IN MEDICINE, 2024, 11
  • [27] Quality of life and physical activity level in patients with chronic kidney disease during COVID-19 pandemic
    Firat, Merve
    Vardar-Yagli, Naciye
    Saglam, Melda
    Yildirim, Tolga
    Erdem, Yunus
    PSYCHOLOGY HEALTH & MEDICINE, 2023, 28 (03) : 640 - 647
  • [28] Management of patients with autoimmune liver disease during COVID-19 pandemic
    Lleo, Ana
    Invernizzi, Pietro
    Lohse, Ansgar W.
    Aghemo, Alessio
    Carbone, Marco
    JOURNAL OF HEPATOLOGY, 2020, 73 (02) : 453 - 455
  • [29] Exacerbated Worsening of Negative Mood in Underage Drinkers During the COVID-19 Pandemic
    Neppala, Gopi
    Terkuhle, Isabel
    Wagner, Ariella
    Ivanov, Iliyan
    Parvaz, Muhammad A.
    BIOLOGICAL PSYCHIATRY, 2021, 89 (09) : S330 - S330
  • [30] Considerations for Patients With Peripheral Artery Disease During the COVID-19 Pandemic
    Farhan, Serdar
    Kamran, Haroon
    Vogel, Birgit
    Garg, Karan
    Rao, Ajit
    Narula, Navneet
    Jacobowitz, Glenn
    Tarricone, Arthur
    Kapur, Vishal
    Faries, Peter
    Marin, Michael
    Narula, Jagat
    Lookstein, Robert
    Olin, Jeffrey W.
    Krishnan, Prakash
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2021, 27